ArticleFrontiers in bioengineering and biotechnology2026
Mechanism and application of Taq DNA polymerase in TaqMan qPCR.
Article in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
TaqMan quantitative real-time PCR (qPCR) is widely used in molecular biology due to its high specificity, sensitivity, and multiplexing capability. Taq DNA polymerase (Taq pol) plays a central role by simultaneously catalyzing DNA synthesis and cleaving fluorogenic probes, yet the mechanistic interplay between these activities remains incompletely characterized. We systematically quantified Taq pol nuclease and polymerase activities during extension and probe cleavage. A novel screening assay integrating both extension and cleavage readouts was developed to accurately evaluate Taq pol performance. Several engineered Taq variants and KlenTaq (lacking the 5'-3' exonuclease domain) were subsequently analyzed. Our analysis revealed a synergistic relationship between polymerase extension and probe cleavage activities. Two Taq variants exhibited significantly enhanced probe cleavage efficiency, while KlenTaq demonstrated markedly stronger strand displacement activity. These findings elucidate the molecular mechanisms governing Taq pol activity during qPCR. The identified variants with improved cleavage efficiency are promising for multiplex detection, whereas KlenTaq's enhanced strand displacement supports specialized applications such as probe melting curve analysis. This work provides both theoretical insights and practical tools to optimize qPCR assays and engineer next-generation polymerases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.